Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemia
- 30 November 1994
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 18 (11), 811-814
- https://doi.org/10.1016/0145-2126(94)90160-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemiaLeukemia Research, 1994
- Thiopurine methyltransferase activity in American white subjects and black subjectsClinical Pharmacology & Therapeutics, 1994
- Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia.Archives of Disease in Childhood, 1993
- Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?British Journal of Cancer, 1993
- Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipientThe Lancet, 1993
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineagesBiochemical Pharmacology, 1988
- Dissimilar actions of 6-mercaptopurine and 6-thioguanine in Chinese hamster ovary cellsBiochemical Pharmacology, 1985
- 6-Methylthioguanylic acid, a metabolite of 6-thioguanineBiochemical Pharmacology, 1971
- Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotidesBiochemical Pharmacology, 1969